APO IMA 100 (Imatinib Mesylate 100 mg)
Pill with imprint APO IMA 100 is Orange, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Apotex Corp..
Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; chronic eosinophilic leukemia; myeloproliferative disorders; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO IMA 100
Imatinib Mesylate
- Imprint:
- APO IMA 100
- Strength:
- 100 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2900
More about imatinib
- Imatinib Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Consumer resources
Other brands: Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
